How to Buy Atricure Stock
Atricure Inc
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
Atricure stock last closed at $20.89, down 5.99% from the previous day, and has decreased 56.78% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.45 percentage points. Atricure stock is currently +3.47% from its 52-week low of $20.19, and -64.96% from its 52-week high of $59.61.
At the moment, there are 48.38M shares of ATRC outstanding. The market cap of ATRC is $1.01B. In the past 24 hours, 961,709 ATRC shares were traded.
How to Buy Atricure Stock
Wondering how to invest in Atricure stock? Here's how.
- Choose where to buy Atricure stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Atricure stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Select your method of payment and add your information.
- Evaluate Atricure stock: The Atricure ticker symbol is ATRC. Is Atricure stock a good investment? Should you buy shares of ATRC? How do ATRC's underlying business fundamentals look? Do top analysts think Atricure is a good buy? Why has ATRC's stock price moved recently? (Hint: Our stock research website can help you decide if ATRC is a good stock to buy).
- Place your ATRC trade: Decide if you will purchase ATRC shares at the current market price or use a limit order to buy ATRC stock at a given price.
- Watch your investment in ATRC: Create a watchlist to keep track of your investment in Atricure stock.
Step 1: Choose where to buy Atricure stock
You need a brokerage account to access the NASDAQ market and buy ATRC stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Industrials, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you are able to invest in ATRC today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start your new brokerage account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've created your account on apps for stocks, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring funds into your new brokerage account.
Step 4: Evaluate Atricure stock
After you have figured out the best place to buy Atricure stock, it's critical to analyze their stock before you invest, so you can wrap your head around the risk and opportunity.
Atricure Numbers
Atricure Fundamentals
WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ATRC's stock page.
Is ATRC stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge ATRC's intrinsic value.
Using relative valuations ratios:
- ATRC may be undervalued based on its P/B ratio of 2.21x, relative to Medical Instruments & Supplies industry P/B ratio of 3.54x
You can access additional valuation analysis on ATRC's stock here.
ATRC Financials at a glance
Passed Health Checks:
- Total ATRC debt is lower than 5 years ago, relative to shareholder equity.
- ATRC profit margin has gone up from -10.8% to -9% in the past year.
- There are more short-term assets than short-term liabilities on the ATRC balance sheet.
- ATRC has cash burn of 54723000. It has sufficient cash and short-term investments to cover this for at least one year.
- ATRC has a low debt to equity ratio of 0.3.
- There are more short-term assets than long-term liabilities on the ATRC balance sheet.
Failed Health Checks:
- ATRC has $105.96M in cash and short term investments. This is not sufficient to cover its annual cash burn of $54.72M.
Is it a good time to buy Atricure stock, according to Wall Street analysts?
Out of 7 Equities analysts who monitor ATRC, the consensus analyst rating on Atricure is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent ATRC Analyst Upgrades/Downgrades
Rick Wise, a top 7% analyst from Stifel Nicolaus maintains ATRC with a strong buy rating and lowers their ATRC price target from $50.00 to $42.00, on Feb 16, 2024.
Daniel Stauder, a bottom 25% analyst from JMP Securities reiterates ATRC with a buy rating and maintains their ATRC price target from $60.00 to $60.00, on Nov 29, 2023.
You can dig deeper into what analysts are forecasting on the Atricure stock forecast page.
ATRC Technicals
How is ATRC performing as a company?
Last year, ATRC revenue was $414.60M. During the last 5 year, ATRC's revenue has increased by 14.73% per year. This was faster than the Medical Instruments & Supplies industry average of 9.52%.
You can analyze ATRC's earnings and revenue performance here.
Are ATRC insiders buying or selling the stock?
In the last year, executives and large shareholders at ATRC have sold more shares than they have bought.
Justin J. Noznesky, Chief Mktg Strategy Officer of ATRC, was the latest ATRC insider to sell. They sold $36,135.00 worth of ATRC shares on May 1, 2024.
Dig into more about who owns ATRC stock here.
Does ATRC stock generate passive income?
No, Atricure doesn't provide an income stream by paying out dividends.
What do other investors have to say about ATRC?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your ATRC trade
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, use a limit order.
Click the Open Trade button and your broker will place the order.
If you want additional help investing in stocks on eToro, watch the how to video below:
Step 6: Watch your investment in ATRC
Now that you own some ATRC stock, you'll want to stay up-to-date on your investment.
Start a watchlist to keep tabs on your ATRC stock.
ATRC Feed
How to Buy Stock in Atricure
To reiterate, here are the 6 steps to buy Atricure stock:
- Choose where to buy Atricure stock
- Sign up for a brokerage account
- Fund your brokerage account
- Evaluate Atricure stock
- Place your ATRC trade
- Watch your investment in ATRC
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your new investment in Atricure, click below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.